Myozyme
Myozyme is a medicine authorised by Swissmedic under authorisation number 58038. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 May 2008 and the authorisation is valid without a time limit. ATC code A16AB07 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 58038 |
|---|---|
| Name | Myozyme |
| Full name | Myozyme, Poudre pour solution à diluer pour perfusion |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | A16AB07 |
| First authorisation | 22 May 2008 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Myozyme, Poudre pour solution à diluer pour perfusion | A | 22 May 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | A16AB07 | 07.14.0. | A |
| 2 | 25 | Durchstechflasche(n) | A16AB07 | 07.14.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Myozyme authorised in Switzerland?
Yes. Myozyme is authorised by Swissmedic under authorisation number 58038, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Myozyme have?
Myozyme is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Myozyme?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.